https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-27 / Crit. Rev. Oncol. Hematol. 2017 Mar;111:87-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-27 / Crit. Rev. Oncol. Hematol. 2017 Mar;111:87-932017-01-27 00:00:002019-02-15 08:51:20Immunotherapy for the treatment of multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-25 / J Clin Pharm Ther 2017 Apr;42(2):155-164
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-25 / J Clin Pharm Ther 2017 Apr;42(2):155-1642017-01-25 00:00:002017-01-25 00:00:00Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-24 / Oncotarget 2017 Jan;8(4):7157-7174
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-24 / Oncotarget 2017 Jan;8(4):7157-71742017-01-24 00:00:002019-02-15 08:36:13Targeting immune checkpoints in malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-21 / J Neurooncol 2017 04;132(2):255-266
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-21 / J Neurooncol 2017 04;132(2):255-2662017-01-21 00:00:002021-11-15 20:06:08Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-17 / Oncotarget 2017 Jan;8(3):5339-5348
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-17 / Oncotarget 2017 Jan;8(3):5339-53482017-01-17 00:00:002017-01-17 00:00:00Regional hyperthermia combined with radiotherapy for esophageal squamous cell carcinoma with supraclavicular lymph node metastasis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-10 / Clin. Cancer Res. 2017 07;23(13):3352-3364
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-10 / Clin. Cancer Res. 2017 07;23(13):3352-33642017-01-10 00:00:002019-02-15 08:53:10Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-06 / Pharmacotherapy 2017 01;37(1):129-143
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-06 / Pharmacotherapy 2017 01;37(1):129-1432017-01-06 00:00:002019-02-15 08:51:21Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2017-01-01 12:20:372019-02-10 12:20:56Artikel:Deutsches Ärzteblatt: Präoperativer Impfstoff zeigt in Studie erste Wirkung
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-01 / Adv Exp Med Biol 2017;1026:315-330
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-01 / Adv Exp Med Biol 2017;1026:315-3302017-01-01 00:00:002017-01-01 00:00:00Progress in Vaccine Therapies for Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-01 / Curr Cancer Drug Targets 2017;17(9):782-805
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-01 / Curr Cancer Drug Targets 2017;17(9):782-8052017-01-01 00:00:002019-02-15 08:36:11Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
